Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Maria de Lourdes Albuquerque de Queiroga"'
Autor:
Maria de Lourdes Albuquerque de QUEIROGA, Raymundo PARANÁ, José Eymard Moraes de MEDEIROS FILHO, Giovannini Cesar A FIGUEIREDO, Ananda Peixoto de ARAÚJO, Hagley Walson Soares LEITE, Itiel de Souza AQUINO, Leonardo Honório de A MELO NETO
Publikováno v:
Arquivos de Gastroenterologia, Vol 52, Iss 3, Pp 239-246 (2015)
BackgroundThe standard treatment of chronic hepatitis C is the administration of pegylated interferon α2a or α2b in combination with ribavirin, but adverse effects can be observed, as well as the high cost of this therapy. Therefore, there is inter
Externí odkaz:
https://doaj.org/article/7a489bbfd7d249078872f4eb4ec176ce
Autor:
Priscila Werton Alves, Maria de Lourdes Albuquerque de Queiroga, Ingrácin Lima Diniz Basílio, Marília Marques Pereira Lira, Damião Flávio dos Santos
Publikováno v:
Research, Society and Development; Vol. 12 No. 1; e9812139499
Research, Society and Development; Vol. 12 Núm. 1; e9812139499
Research, Society and Development; v. 12 n. 1; e9812139499
Research, Society and Development
Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI
Research, Society and Development; Vol. 12 Núm. 1; e9812139499
Research, Society and Development; v. 12 n. 1; e9812139499
Research, Society and Development
Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI
Chronic hepatitis C is a silent evolution disease that can lead to outcomes such as liver cirrhosis and hepatocellular carcinoma (HCC), a public health problem due to high universal morbidity. It is transmitted by single-stranded ribonucleic acid (RN
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9eb34855978d258d75a62449b6f182e
https://rsdjournal.org/index.php/rsd/article/view/39499
https://rsdjournal.org/index.php/rsd/article/view/39499
